| Name | 1629138-41-5 |
|---|---|
| Synonyms |
SRI-011381 HCL
1-benzyl-3-cyclohexyl-1-(piperidin-4-ylmethyl)urea SRI-011381 SRI011381 N'-Cyclohexyl-N-(phenylmethyl)-N-(4-piperidinylmethyl)-urea Urea, N'-cyclohexyl-N-(phenylmethyl)-N-(4-piperidinylmethyl) SRI-011381, 10 mM in DMSO N'-Cyclohexyl-N-(phenylmethyl)-N-(4-piperidinylmethyl)-urea MFCD01475985 Transforming owth factor beta,SRI011381,inhibit,multiple,neuroprotective,NALP3,collagen-1,SRI-011381,SRI 011381,TGF-β,sclerosis,Inhibitor,α-SMA,TGF-beta/Smad SRI-011381 (C381) |
| Description | SRI-011381 is an orally active TGF-β signaling agonist, exhibits neuroprotective effects[1][2]. |
|---|---|
| Related Catalog | |
| In Vitro | SRI-011381 (10 μM) promotes the proliferation of mouse lung fibroblasts, and significantly increases TGF-β1, NALP3, collagen-1, and α-SMA expression[1]. |
| In Vivo | SRI-011381 (30 mg/kg; i.p.; every 2 d; for 22 days) partially rescues the deficits in optic nerve and retina of YAPGFAP-CKO EAE mice[2]. Animal Model: YAPGFAP-CKO mice bearing experimental autoimmune encephalomyelitis (EAE)[2] Dosage: 30 mg/kg Administration: Intraperitoneally injection; every 2 d; for 22 days Result: Significantly inhibited inflammatory infiltration and relieved the loss of neurons in YAPGFAP-CKO EAE mice. |
| References |
| Molecular Formula | C20H31N3O |
|---|---|
| Molecular Weight | 329.48 |